Asymchem

Asymchem (Stock Code: 002821.SZ/6821.HK), a global CDMO leader, has provided one-stop pharmaceutical solutions for over 25 years. With a strong foundation in small molecule services, it has advanced capabilities in chemical macromolecules, biologics, drug products, clinical research, synthetic biology, and technology transfer. Supported by 9,000+ professionals—45% in R&D—and facilities in China, the U.S., the U.K., and beyond, Asymchem adheres to top-tier cGMP and EHS standards. Trusted by global pharma and biotech leaders, Asymchem delivers high-quality, cost-effective services, reducing time-to-market for therapies and providing client-centric solutions to meet the diverse needs of global drug development.